Guardant Health Shares Slide After Patent-Infringement Verdict
By Colin Kellaher Guardant Health shares fell sharply Wednesday after the precision-oncology company was hit with a patent-infringement verdict topping $80...
Twinstrand Biosciences Colin Kellaher Guardant Health University Of Washington Us District Court Palo Alto
Source: marketwatch.com